Skip to content

April 4, 2022

The Official Agent Orange Presumptive List: Top 40+ Conditions and Their VA Ratings (2022 Update)

In this post, I’ll reveal and explain the official Agent Orange Presumptive List 2022 of more than 40 conditions and their VA ratings for presumptive service connection due to Agent Orange Exposure. 

In our experience, Agent Orange Presumptives are easy to win because you just need to show on your DD 214 that you were deployed to an eligible location during a specific period, and that you developed a qualifying condition as a result.

VA Ratings for Agent Orange presumptive conditions range from 0% to 100%, depending on the disability name and its severity of symptoms.

Many VA presumptive conditions for Agent Orange are not in the VA Schedule for Rating Disabilities, and thus, are rated analogously to the closest condition with similar symptoms.

The DCs we’ve listed below are the most likely codes for these conditions; however, VA Raters may choose to apply different diagnostic codes depending on the diagnosis and severity of symptoms.

Okay, let’s get started.

Table of Contents

What is a “Presumptive Disability” for Agent Orange Exposure?

What is a presumptive VA disability

A presumptive disability for Agent Orange exposure is one that the VA “presumes” to be service-connected, even if there’s no specific Nexus (“link” or “connection”) for service connection.

Presumptive disability for Agent Orange works like this: If you served at X location during the qualifying period and developed Y condition as a result, then X + Y = automatic service connection.

Instead of having to prove a service connected disability, you only need show with your DD 214 that you were deployed to an eligible location for Agent Orange Exposure during a specific period, and that you developed a qualifying condition as a result.

We also recommend you write and submit a strong personal Statement in Support of a Claim.

Buddy letters, written by a first-hand witness, can be helpful to fill-in gaps in your service treatment records and military personnel records.

How does the VA Define an Herbicide Agent?

How does the VA Define an Herbicide Agent

Per 38 CFR 3.307(a)(6)(i), an Herbicide Agent means a harmful defoliant chemical, such as Agent Orange, used in support of U.S. and allied military operations in the RVN during the period beginning on January 9, 1962, and ending on May 7, 1975, that contained the following components:

  • 2,4,5-T and its contaminant, TCDD (Dioxin)
  • 2,4-D
  • Cacodylic acid, and
  • Picloram

Examples:

  • Agent Orange (2,4,5-T and 2,4-D)
  • Agent White (2,4-D and picloram), and
  • Agent Blue (cacodylic acid)

What is the Agent Orange Presumptive List?

Agent Orange Presumptive List

The herbicide Agent Orange was used in both Vietnam and Korea during the 1960s and 1970s.

There are numerous duty locations and qualifying active duty service that could have exposed a veteran to Agent Orange.

Any length of service qualifies.

The standard “90-day rule” does not apply to veterans exposed to Agent Orange.

Let’s explore each eligible location and type of service.

Vietnam and Thailand:

Vietnam Veterans who served between January 9, 1962, and May 7, 1975, are presumed to have been exposed to Agent Orange (unless there is solid evidence that they were not) if they served:

  • In Vietnam (must have served at least one-day deployed to Vietnam)
  • Blue Water Veterans who served within 12 nautical miles of the shores of Vietnam
  • On or near military bases in Thailand, including U-Tapao, Ubon, Nakhon Phanom, Takhli, Korat, or Don Muang

South Korea:

Korean Veterans who served in the Korean DMZ between September 1, 1967, and August 31, 1971, are presumed to have been exposed to Agent Orange (unless there is solid evidence that they were not).

Air Force C-123s:

Veterans who had repeated contact with contaminated C-123s after the war also qualify as having been exposed to Agent Orange (see the VA’s list of Air Force Speciality DCs and Units for specifics on C-123 qualifications).

Testing, Storage, or Disposal of Agent Orange:

Other veterans exposed to Agent Orange can qualify for presumptive disability benefits if they can show proof that they served where herbicides were tested or stored outside of Vietnam or were involved in the testing, storage, or disposal of herbicides in the U.S.

See the full list of locations.

Reservists:

Reservists meet the requirements for Agent Orange exposure if they performed flight, ground, or medical crew duties at:

  • Lockbourne/Rickenbacker Air Force Base (Ohio) between 1969 and 1986 in the 906th and 907th Tactical Air Groups or the 355th and 356th Tactical Airlift Squadrons
  • Pittsburgh International Airport (Pennsylvania) between 1972 and 1982 in the 758th Airlift Squadron
  • Westover Air Force Base (Massachusetts) between 1972 and 1982 in the 731st Tactical Air Squadron and 74th Aeromedical Evacuation Squadron, or 901st Organizational Maintenance Squadron

The Official Agent Orange Presumptive List (2022)

The Official Agent Orange Presumptive List 2022

There are many diseases of Agent Orange, and the following 42 conditions comprise the official Agent Orange Presumptive List for VA disability benefits.

This list includes 29 different types of Agent Orange Cancers.

#1. Primary amyloidosis, DC 7717

Primary amyloidosis is a rare disease that occurs when an abnormal protein (amyloid) builds-up in your organs and interferes with their normal function, which has been directly connected to Agent Orange exposure.

The VA rates Primary amyloidosis under CFR Title 38, Part 4, Schedule for Rating Disabilities, DC 7717, Primary amyloidosis.

The only VA rating for Amyloidosis (primary amyloidosis) due to Agent Orange exposure is 100 percent.

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its report “Veterans and Agent Orange: Update 1996” released on July 27, 2007, that “there is limited or suggestive evidence of an association between exposures to the compounds of interest found in the herbicide Agent Orange and AL amyloidosis.”

#2. Chloracne or similar acneform disease, DC 7829 (must manifest to 10% within 1 year of last exposure)

Chloracne is a rare skin eruption of blackheads, cysts, and nodules.

Chloracne has been directly linked to Agent Orange exposure.

The VA rates Chloracne under CFR Title 38, Part 4, Schedule for Rating Disabilities, DC 7829, Chloracne.

VA ratings for Chloracne range from 0 percent to 30 percent, with breaks at 10 percent and 20 percent, depending on the frequency, severity, and duration of symptoms.

The highest scheduler rating for Chloracne is 30%.

What are the VA ratings for Chloracne due to Agent Orange exposure?

  • Chloracne with deep acne (deep inflamed nodules and pus-filled cysts) affecting 40 percent or more of the face and neck rate at 30%.
  • Chloracne with deep acne (deep inflamed nodules and pus-filled cysts) affecting the intertriginous areas (the axilla of the arm, the anogenital region, skin folds of the breasts, or between digits) rate at 20%.
  • Chloracne with deep acne (deep inflamed nodules and pus-filled cysts) affecting less than 40 percent of the face and neck; or deep acne affecting non-intertriginous areas of the body (other than the face and neck) rate at 10%.
  • With superficial acne (comedones, papules, pustules) of any extent rate at 0%.

Pro Tip: VA raters can also rate Chloracne or similar acneform disease under disfigurement of the head, face, or neck (DC 7800) or scars (DCs 7801, 7802, 7804, or 7805), depending upon the predominant disability.

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report on “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam“, as well as in its 2014 update and previous updates, that there is a positive association between Chloracne and exposure to dioxin in Agent Orange.

#3. Type 2 Diabetes, DC 7913

Type 2 Diabetes is a condition that affects the way the body regulates and uses sugar (glucose) as a fuel.

This long-term (chronic) condition results in too much sugar circulating in the bloodstream.

Eventually, high blood sugar levels can lead to other disorders of the circulatory, nervous, and immune systems.

The VA rates Type 2 Diabetes under CFR Title 38, Part 4, Schedule for Rating Disabilities, DC 7913, Diabetes Mellitus.

The VA ratings for Diabetes (Type 2) are 10%, 20%, 40%, 60%, or 100%.

The highest scheduler rating for Diabetes is 100%.

What are the VA ratings for Type 2 Diabetes due to Agent Orange exposure?

  • Requiring more than one daily injection of insulin, restricted diet, and regulation of activities (avoidance of strenuous occupational and recreational activities) with episodes of ketoacidosis or hypoglycemic reactions requiring at least three hospitalizations per year or weekly visits to a diabetic care provider, plus either progressive loss of weight and strength or complications that would be compensable if separately evaluated rate at 100 percent.
  • Requiring one or more daily injection of insulin, restricted diet, and regulation of activities with episodes of ketoacidosis or hypoglycemic reactions requiring one or two hospitalizations per year or twice a month visits to a diabetic care provider, plus complications that would not be compensable if separately evaluated rate at 60 percent. 
  • Requiring one or more daily injection of insulin, restricted diet, and regulation of activities rate at 40 percent.
  • Requiring one or more daily injection of insulin and restricted diet, or oral hypoglycemic agent and restricted diet rate at 20 percent.
  • Manageable by restricted diet only rate at 10 percent. 

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 2000 report, Veterans and Agent Orange: Herbicide/Dioxin Exposure and Type 2 Diabetes, as well as in 2002 and 2004 updates, that there is limited/suggestive evidence of an association between exposure to herbicides and type 2 diabetes.

#4. Hodgkin’s disease, DC 7709

Hodgkin’s lymphoma is a form of cancer that affects the lymphatic system, which is part of the body’s germ-fighting immune system.

In Hodgkin’s lymphoma, white blood cells called lymphocytes grow out of control, causing swollen lymph nodes and growths throughout the body.

Hodgkin’s disease has been linked directly to Agent Orange exposure.

The VA rates Hodgkin’s disease under CFR Title 38, Part 4, Schedule for Rating Disabilities, DC 7709, Hodgkin’s Lymphoma.

What is the VA rating for Hodgkin’s Lymphoma due to Agent Orange?

The VA assigns a 100 percent VA rating for Hodgkin’s lymphoma with active disease or during a treatment phase.

Note: A 100 percent rating for Hodgkin’s lymphoma shall continue beyond the cessation of any surgical therapy, radiation therapy, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any reduction in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local recurrence or metastasis, rate on residuals under the appropriate diagnostic code(s).

Medical Research: The Health and Medicine Division (HMD) (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report on “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and in future updates that there is sufficient evidence of a positive association between exposure to the herbicides used in Vietnam and the development of Hodgkin’s disease.

#5. Ischemic heart disease, DC 7005 (does not include high blood pressure, peripheral vascular disease, or stroke)

Ischemic Heart Disease, also called Myocardial Ischemia, occurs when blood flow to your heart is reduced, preventing the heart muscle from receiving enough oxygen.

The reduced blood flow is usually the result of a partial or complete blockage of your heart’s arteries.

Ischemic Heart Disease has been linked to Agent Orange exposure.

The VA rates Ischemic Heart Disease under CFR 38, Part 4, VA Schedule of Ratings, the General Rating Formula for Diseases of the Heart, Diagnostic Code 7005, Arteriosclerotic heart disease (coronary artery disease).

VA Ratings for Heart Disease range from 10% to 100% with breaks at 30% and 60%.

The highest scheduler rating for Ischemic Heart Disease is 100%, which means your workload of 3.0 METs or less results in heart failure symptoms.

What are the VA disability ratings for Ischemic Heart Disease due to Agent Orange?

  • Workload of 3.0 METs or less results in heart failure symptoms rate at 100%.
  • Workload of 3.1-5.0 METs results in heart failure symptoms rate at 60%.
  • Workload of 5.1-7.0 METs results in heart failure symptoms; or evidence of cardiac hypertrophy or dilatation confirmed by echocardiogram or equivalent (e.g., multigated acquisition scan or magnetic resonance imaging) rate at 30%.
  • Workload of 7.1-10.0 METs results in heart failure symptoms; or continuous medication required for control rate at 10%.

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine determined in its research report “Veterans and Agent Orange: Update 2008” that there is “suggestive but limited evidence that exposure to Agent Orange and other herbicides used during the Vietnam War is associated with an increased chance of developing ischemic heart disease.”

#6. All chronic B-cell leukemias, DC 7703

Leukemia is a type of cancer of the blood cells.

B-cells are a specific type of lymph cell that affect a body’s immune system.

There are two types of B-cell leukemia: prolymphocytic leukemia (PLL) and hairy cell leukemia (HCL).

Chronic lymphocytic leukemia is the most common form of leukemia and is a type of cancer of the blood and bone marrow.

Medical research has concluded that there is sufficient evidence of an association between exposure to Agent Orange and chronic lymphocytic leukemia, including hairy cell leukemia and other chronic B-cell leukemias.

The VA rates Chronic B-cell Leukemia under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 7703, Leukemia (except for chronic myelogenous leukemia).

The VA assigns a 100 percent VA rating for Chronic B-cell Leukemia with an active disease or during a treatment phase.

However, the VA rates Chronic lymphocytic leukemia or monoclonal B-cell lymphocytosis (MBL), asymptomatic, in the Rai Stage 0, at 0 percent.

What are the VA disability ratings for Leukemia due to Agent Orange exposure?

  • Leukemia with an active disease or during a treatment phase rate at 100%.
  • Chronic lymphocytic leukemia or monoclonal B-cell lymphocytosis (MBL), asymptomatic, in the Rai Stage 0 rate at 0%.
  • Otherwise rate Leukemia residuals under the appropriate diagnostic code(s)

Note (1): A 100 percent evaluation shall continue beyond the cessation of any surgical therapy, radiation therapy, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no recurrence, rate on residuals.

Note (2): Evaluate symptomatic chronic lymphocytic leukemia that is at Rai Stage I, II, III, or IV the same as any other leukemia evaluated under this diagnostic code.

Note (3): Evaluate residuals of leukemia or leukemia therapy under the appropriate diagnostic code(s). Myeloproliferative Disorders: (Diagnostic Codes 7704, 7718, 7719).

Medical Research: The Health and Medicine Division (HMD) (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine focused on chronic lymphocytic leukemia in its report “Veterans and Agent Orange: Update 2002” and concluded that there is sufficient evidence of an association between exposure to herbicides and chronic lymphocytic leukemia.

#7. Multiple myeloma, DC 7712

Multiple myeloma is a cancer that forms in plasma cells, which are part of white blood cells.

Healthy plasma cells help you fight infections by making antibodies that recognize and attack germs.

In multiple myeloma, cancerous plasma cells accumulate in the bone marrow and crowd out healthy blood cells.

It is called “multiple myeloma” because it is characterized by plasma cell tumors in bones in multiple parts of the body.

The VA rates Multiple myeloma under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 7712, Multiple myeloma.

The VA rating for “symptomatic” Multiple myeloma is 100 percent.

Multiple myeloma that’s asymptomatic, smoldering, or monoclonal gammopathy of undetermined significance (MGUS) is rated at 0 percent.

What are the VA ratings for Multiple myeloma due to Agent Orange exposure?

  • Multiple myeloma symptomatic rate at 100%.
  • Multiple myeloma asymptomatic, smoldering, or monoclonal gammopathy of undetermined significance (MGUS) rate at 0%.

Note (1): Current validated biomarkers of symptomatic multiple myeloma and asymptomatic multiple myeloma, smoldering, or monoclonal gammopathy of undetermined significance (MGUS) are acceptable for the diagnosis of multiple myeloma as defined by the American Society of Hematology (ASH) and International Myeloma Working Group (IMWG)

Note (2): The 100 percent evaluation shall continue for five years after the diagnosis of symptomatic multiple myeloma, at which time the appropriate disability evaluation shall be determined by mandatory VA examination. Any reduction in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) and § 3.344 (a) and (b).

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report on “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and in 1996, 1998, 2002, and 2004 updates, that there is limited/suggestive evidence of an association between exposure to the herbicides used in Vietnam and the development of multiple myeloma.

#8. Non-Hodgkin’s lymphoma, DC 7715 (Blue Water Veterans eligible for this condition)

Non-Hodgkin lymphoma, also known as NHL or just lymphoma, is a cancer that starts in white blood cells called “lymphocytes,” which are part of the body’s immune system.

Medical research has found sufficient evidence of a positive association between exposure to Agent Orange and non-Hodgkin’s lymphoma.

The VA rates Non-Hodgkin lymphoma under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 7715, Non-Hodgkin’s lymphoma.

What is the VA rating for Non-Hodgkin’s lymphoma due to Agent Orange exposure?

The VA rating for Non-Hodgkin’s lymphoma as an active disease, during treatment, or with low grade NHL is 100 percent.

Note: A 100 percent evaluation for non-Hodkin’s lymphoma due to Agent Orange exposure shall continue beyond the cessation of any surgical therapy, radiation therapy, antineoplastic chemotherapy, or other therapeutic procedures. Two years after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any reduction in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no recurrence, rate on residuals under the appropriate diagnostic code(s)

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report on “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and in future updates that there is sufficient evidence of a positive association between exposure to herbicides (2,4-D; 2,4,5-T and its contaminant TCDD; cacodylic acid; and picloram) and non-Hodgkin’s lymphoma.

#9. Parkinson’s disease, DC 8004

Parkinson’s disease is a degenerative brain disorder that causes shaking, stiffness, and difficulty with walking, balance, and coordination.

Symptoms usually start slowly but get progressively worse over time.

Parkinson’s disease has been directly linked to Agent Orange exposure.

The VA rates Parkinson’s disease under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 8004, Paralysis agitans.

What is the VA rating for Parkinson’s due to Agent Orange exposure?

The only scheduler disability rating available for Parkinson’s disease is 30 percent.

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its report “Veterans and Agent Orange: Update 2008” released July 24, 2009, that there is “suggestive but limited evidence that exposure to Agent Orange and other herbicides used during the Vietnam War is associated with an increased chance of developing Parkinson’s disease.”

#10. Peripheral neuropathy, DC 8520 (must manifest to 10% within 1 year of last exposure)

Peripheral Neuropathy is the result of damage to the nerves located outside of the brain and spinal cord (peripheral nerves).

It can cause weakness, numbness, and pain—typically in the hands and feet.

Medical research has determined there is evidence of an association between Peripheral Neuropathy and exposure to Agent Orange.

Since there is no separate DC for Peripheral Neuropathy, the VA rates it by analogy under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code (DC) 8520, Paralysis of the Sciatic Nerve.

VA Ratings for Peripheral Neuropathy range from 10 percent to 80 percent, with breaks at 20 percent, 40 percent, and 60 percent.

The highest scheduler rating for Peripheral Neuropathy is 80%.

What are the VA disability ratings for Peripheral Neuropathy due to Agent Orange?

  • 80%: Complete paralysis; the foot dangles and drops, no active movement possible of muscles below the knee, flexion of knee weakened or lost
  • 60%: Incomplete paralysis, severe with “marked muscular atrophy”
  • 40%: Incomplete paralysis, moderately severe
  • 20%: Incomplete paralysis, moderate
  • 10%: Incomplete paralysis, mild with flexion of knee weakened or (very rarely) lost

Pro Tip: A Limitation of Range of Motion (ROM) test with a goniometer should be performed at your C&P exam for Peripheral Neuropathy. Make the doctor stop as soon as you feel pain!

Medical Research: The Health and Medicine Division report Veterans and Agent Orange: Update 2010 determined there is “limited or suggestive evidence of an association” between herbicide exposure and “early-onset peripheral neuropathy that may be persistent.” In response to this report, VA eliminated the requirement that acute and subacute peripheral neuropathy appear “within weeks or months” after exposure and resolve within two years.

#11. Porphyria cutanea tarda (PCT), DC 7815 (must manifest to 10% within 1 year of last exposure)

Porphyria cutanea tarda (PCT) is a rare skin disorder characterized by painful, blistering skin lesions that develop on sun-exposed skin.

Affected skin may peel or blister.

Medical research has determined there is evidence of an association between Porphyria cutanea tarda (PCT) and exposure to Agent Orange.

The VA rates Porphyria cutanea tarda (PCT) under CFR 38, Part 4, VA Schedule of Ratings, General Rating Formula for the Skin, Diagnostic Code 7815, Bullous disorders (including pemphigus vulgaris, pemphigus foliaceous, bullous pemphigoid, dermatitis herpetiformis, epidermolysis bullosa acquisita, benign chronic familial pemphigus (Hailey-Hailey), and porphyria cutanea tarda).

This condition is either rated under the basic rating system for skin conditions or as scars/disfigurement, whichever best describes the disability.

VA Ratings for Porphyria cutanea tarda due to Agent Orange exposure range from 10 percent to 60 percent with a break at 30 percent.

What are the VA ratings for Porphyria cutanea tarda (PCT) due to Agent Orange?

The 60% rating for Porphyria cutanea tarda (PCT) must include symptoms of at least one of the following:

  • Characteristic lesions involving more than 40 percent of the entire body, or more than 40 percent of exposed areas affected, or
  • Constant or near-constant systemic therapy including, but not limited to, corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, psoralen with long-wave ultraviolet-A light (PUVA), or other immunosuppressive drugs required over the past 12-month period.

The 30% rating for Porphyria cutanea tarda (PCT) must include symptoms of at least one of the following:

  • Characteristic lesions involving 20 to 40 percent of the entire body or 20 to 40 percent of exposed areas affected; or Systemic therapy including, but not limited to, corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, PUVA, or
  • Other immunosuppressive drugs required for a total duration of 6 weeks or more, but not constantly, over the past 12-month period.

The 10% rating for Porphyria cutanea tarda (PCT) must include symptoms of at least one of the following:

  • Characteristic lesions involving at least 5 percent, but less than 20 percent, of the entire body affected; or
  • At least 5 percent, but less than 20 percent, of exposed areas affected; or
  • Intermittent systemic therapy including, but not limited to, corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, PUVA, or other immunosuppressive drugs required for a total duration of less than 6 weeks over the past 12-month period.

Note: The VA must also rate complications and residuals of mucosal involvement (ocular, oral, gastrointestinal, respiratory, or genitourinary) separately under the appropriate diagnostic code.

Pro Tip: Using VA.gov, you should upload pictures of your Eczema for the C&P examiner and VA Rater. It’s the #1 best way to prove you have Eczema and how much of your body they cover.

Medical Research: The Health and Medicine Division (HMD) (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report on “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” that there was sufficient evidence of an association between exposure to herbicides used in Vietnam and PCT. However, in 1996, HMD reviewed new research and determined that there is only limited or suggestive evidence of an association.

#12. Prostate cancer, DC 7528

Prostate cancer is cancer that occurs in the prostate, which is a small walnut-shaped gland in males that produces the seminal fluid for sperm.

There is medical research that supports a causal link between exposure to Agent Orange and Prostate cancer.

The VA rates Prostate cancer under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 7528, Malignant neoplasms of the genitourinary system.

The VA rating for Prostate cancer due to Agent Orange is 100 percent.

What is the VA rating for Prostate cancer due to Agent Orange exposure?

  • Prostate cancer (malignant neoplasms of the genitourinary system) rate at 100%.

Note: Following the cessation of surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure, the rating of 100 percent shall continue with a mandatory VA examination at the expiration of six months. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local reoccurrence or metastasis, rate on residuals as voiding dysfunction or renal dysfunction, whichever is predominant.

Medical Research: A 2013 study conducted at the Portland VA Medical Center and Oregon Health and Science University found that Veterans exposed to Agent Orange are not only at higher risk for prostate cancer, but they are more likely to have aggressive forms of the disease. Read the abstract for the publication, Agent Orange as a risk factor for high-grade prostate cancer.

#13. Lung cancer, DC 6819

Lung cancer is a form of cancer that starts in the lungs.

The lungs are two spongy organs inside the chest that take in oxygen (inhalation) and release carbon dioxide (exhalation).

As of this writing, lung cancer is the leading cause of cancer deaths around the world.

Medical research has determined there is evidence of an association between Lung cancer and exposure to Agent Orange.

The VA rates Lung cancer under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 6819,

Neoplasms, malignant, any specified part of respiratory system exclusive of skin growths.

The VA rating for Lung cancer due to Agent Orange is 100 percent.

What is the VA rating for Lung cancer due to Agent Orange exposure?

  • Lung cancer (Neoplasms, malignant, any specified part of respiratory system exclusive of skin growths) rate at 100%.

Note: A 100 percent VA rating for Lung cancer shall continue beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy, or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local recurrence or metastasis, rate on residuals.

Medical Research: The Health and Medicine Division (HMD) (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and in future updates that there is limited/suggestive evidence of an association between exposure to herbicides (2,4-D; 2,4,5-T and its contaminant TCDD; cacodylic acid; and picloram) and Lung cancer.

#14. Bronchial cancer, DC 6819

Bronchogenic cancer is any type or subtype of lung cancer.

The term was once used to describe only certain lung cancers that began in the bronchi and bronchioles, the passageways to the lungs.

However, today it refers to any type.

Medical research has found evidence of an association between Bronchial cancer and exposure to Agent Orange.

The VA rates Bronchial cancer under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 6819, Neoplasms, malignant, any specified part of respiratory system exclusive of skin growths.

The VA rating for Bronchial cancer due to Agent Orange is 100 percent.

What is the VA rating for Bronchial cancer due to Agent Orange exposure?

  • Bronchial cancer (Neoplasms, malignant, any specified part of respiratory system exclusive of skin growths) rate at 100%.

Note: A 100 percent VA rating for Bronchial cancer shall continue beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy, or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local recurrence or metastasis, rate on residuals.

Medical Research: The Health and Medicine Division (HMD) (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and in future updates that there is limited/suggestive evidence of an association between exposure to herbicides (2,4-D; 2,4,5-T and its contaminant TCDD; cacodylic acid; and picloram) and Bronchial cancer.

#15. Larynx cancer, DC 6819

Laryngeal cancer is a form of cancer in which malignant (cancer) cells form in the tissues of the larynx.

The larynx is a part of the throat between the base of the tongue and the trachea.

Medical research has determined there is evidence of an association between Larynx cancer and exposure to Agent Orange.

The VA rates Larynx cancer under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 6819, Neoplasms, malignant, any specified part of respiratory system exclusive of skin growths.

The VA rating for Larynx cancer due to Agent Orange is 100 percent.

What is the VA rating for Larynx cancer due to Agent Orange exposure?

  • Larynx cancer (Neoplasms, malignant, any specified part of respiratory system exclusive of skin growths) rate at 100%.

Note: A 100 percent VA rating for Larynx cancer shall continue beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy, or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local recurrence or metastasis, rate on residuals.

Medical Research: The Health and Medicine Division (HMD) (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and in future updates that there is limited/suggestive evidence of an association between exposure to herbicides (2,4-D; 2,4,5-T and its contaminant TCDD; cacodylic acid; and picloram) and Larynx cancer.

#16. Trachea cancer, DC 6819

Trachea cancer is a rare type of cancer that forms in your windpipe (Trachea).

The trachea (windpipe) is the airway that runs from your larynx (voice box) to your bronchi, which lead to your lungs.

Medical research has found evidence of an association between Trachea cancer and exposure to Agent Orange.

The VA rates Trachea cancer under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 6819, Neoplasms, malignant, any specified part of respiratory system exclusive of skin growths.

The VA rating for Trachea cancer due to Agent Orange is 100 percent.

What is the VA rating for Trachea cancer due to Agent Orange exposure?

  • Trachea cancer (Neoplasms, malignant, any specified part of respiratory system exclusive of skin growths) rate at 100%.

Note: A 100 percent VA rating for Trachea cancer shall continue beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy, or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local recurrence or metastasis, rate on residuals.

Medical Research: The Health and Medicine Division (HMD) (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and in future updates that there is limited/suggestive evidence of an association between exposure to herbicides (2,4-D; 2,4,5-T and its contaminant TCDD; cacodylic acid; and picloram) and Trachea cancer.

Soft Tissue Sarcomas and Agent Orange Presumptives:

The next 23 conditions on the Agent Orange Presumptive List fall under the category of “Soft Tissue Sarcomas.”

Soft Tissue Sarcomas are cancers that start in soft tissues (muscle, tendons, fat, lymph nodes and blood vessels, and nerves).

While these cancers can develop anywhere in the body, they are found mostly in the arms, legs, chest, and abdomen.

#17. Adult fibrosarcoma, DC 5329

Adult fibrosarcoma is a very rare soft-tissue cancerous tumor or sarcoma.

Fibrous soft tissue is a connective tissue that connects various parts of your body.

For example, your tendons attach muscles to bones; your ligaments attach bones-to-bones.

Medical research has found evidence of a positive association between Adult fibrosarcoma and exposure to Agent Orange.

The VA rates Adult fibrosarcoma under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 5329, Sarcoma, soft tissue (muscle, fat, or fibrous connective tissue).

The VA rating for Adult fibrosarcoma due to Agent Orange is 100 percent.

What is the VA rating for Adult fibrosarcoma cancer due to Agent Orange exposure?

  • Adult fibrosarcoma, soft tissue cancer (muscle, fat, or fibrous connective tissue) rate at 100%.

Note: A rating of 100 percent shall continue beyond the cessation of any surgery, radiation treatment, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local recurrence or metastasis of Adult fibrosarcoma, rate on residual impairment of function.

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and other updates that there is evidence of a positive association between exposure to herbicides used in Vietnam and soft tissue sarcomas.

#18. Dermatofibrosarcoma protuberans (DFSP), DC 5329

Dermatofibrosarcoma protuberans (DFSP) is a very rare form of skin cancer that begins in the connective tissue cells in the middle layer of your skin (dermis).

Medical research has found evidence of a positive association between Dermatofibrosarcoma protuberans and exposure to Agent Orange.

The VA rates Dermatofibrosarcoma protuberans under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 5329, Sarcoma, soft tissue (muscle, fat, or fibrous connective tissue).

The VA rating for Dermatofibrosarcoma protuberans due to Agent Orange is 100 percent.

What is the VA rating for Dermatofibrosarcoma protuberans cancer due to Agent Orange exposure?

  • Dermatofibrosarcoma protuberans, soft tissue cancer (muscle, fat, or fibrous connective tissue) rate at 100%.

Note: A rating of 100 percent shall continue beyond the cessation of any surgery, radiation treatment, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local recurrence or metastasis of Dermatofibrosarcoma protuberans, rate on residual impairment of function.

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and other updates that there is evidence of a positive association between exposure to herbicides used in Vietnam and soft tissue sarcomas.

#19. Malignant fibrous histiocytoma (MFH), DC 5329

Malignant fibrous histiocytoma (MFH) is a type of cancer that usually forms in the soft tissue, but it may also form in bone.

It can occur anywhere in the body, but it usually occurs in the legs (especially the thighs), arms, or back of the abdomen.

Medical research has found evidence of a positive association between Malignant fibrous histiocytoma and exposure to Agent Orange.

The VA rates Malignant fibrous histiocytoma under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 5329, Sarcoma, soft tissue (muscle, fat, or fibrous connective tissue).

The VA rating for Malignant fibrous histiocytoma due to Agent Orange is 100 percent.

What is the VA rating for Malignant fibrous histiocytoma cancer due to Agent Orange exposure?

  • Malignant fibrous histiocytoma, soft tissue cancer (muscle, fat, or fibrous connective tissue) rate at 100%.

Note: A rating of 100 percent shall continue beyond the cessation of any surgery, radiation treatment, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local recurrence or metastasis of Malignant fibrous histiocytoma, rate on residual impairment of function.

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and other updates that there is evidence of a positive association between exposure to herbicides used in Vietnam and soft tissue sarcomas.

#20. Liposarcoma, DC 5329

Liposarcoma is a rare type of cancer that develops in your fatty tissue.

This type of tumor can grow anywhere in your body.

Common places include your abdomen, thigh, and behind your knee.

Medical research has found evidence of a positive association between Liposarcoma and exposure to Agent Orange.

The VA rates Liposarcoma under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 5329, Sarcoma, soft tissue (muscle, fat, or fibrous connective tissue).

The VA rating for Liposarcoma due to Agent Orange is 100 percent.

What is the VA rating for Liposarcoma cancer due to Agent Orange exposure?

  • Liposarcoma, soft tissue cancer (muscle, fat, or fibrous connective tissue) rate at 100%.

Note: A rating of 100 percent shall continue beyond the cessation of any surgery, radiation treatment, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local recurrence or metastasis of Liposarcoma, rate on residual impairment of function.

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and other updates that there is evidence of a positive association between exposure to herbicides used in Vietnam and soft tissue sarcomas.

#21. Leiomyosarcoma (LMS), DC 5329

Leiomyosarcoma (LMS) is a rare type of cancer that grows in the smooth muscles.

The smooth muscles are in the hollow organs of the body, including the intestines, stomach, bladder, and blood vessels.

Medical research has found evidence of a positive association between Leiomyosarcoma and exposure to Agent Orange.

The VA rates Leiomyosarcoma under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 5329, Sarcoma, soft tissue (muscle, fat, or fibrous connective tissue).

The VA rating for Leiomyosarcoma due to Agent Orange is 100 percent.

What is the VA rating for Leiomyosarcoma cancer due to Agent Orange exposure?

  • Leiomyosarcoma, soft tissue cancer (muscle, fat, or fibrous connective tissue) rate at 100%.

Note: A rating of 100 percent shall continue beyond the cessation of any surgery, radiation treatment, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local recurrence or metastasis of Leiomyosarcoma, rate on residual impairment of function.

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and other updates that there is evidence of a positive association between exposure to herbicides used in Vietnam and soft tissue sarcomas.

#22. Epithelioid leiomyosarcoma (malignant leiomyoblastoma), DC 5329

Epithelioid leiomyosarcoma is a special variant of smooth muscle cell tumor.

The tumor (cancer) is characterized not by its spindled component (which is variably present), but by the presence of round and polygonal cells.

Medical research has found evidence of a positive association between Epithelioid leiomyosarcoma (malignant leiomyoblastoma) and exposure to Agent Orange.

The VA rates Epithelioid leiomyosarcoma (malignant leiomyoblastoma) under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 5329, Sarcoma, soft tissue (muscle, fat, or fibrous connective tissue).

The VA rating for Epithelioid leiomyosarcoma (malignant leiomyoblastoma) due to Agent Orange is 100 percent.

What is the VA rating for Epithelioid leiomyosarcoma (malignant leiomyoblastoma) cancer due to Agent Orange exposure?

  • Epithelioid leiomyosarcoma (malignant leiomyoblastoma), soft tissue cancer (muscle, fat, or fibrous connective tissue) rate at 100%.

Note: A rating of 100 percent shall continue beyond the cessation of any surgery, radiation treatment, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local recurrence or metastasis of Epithelioid leiomyosarcoma (malignant leiomyoblastoma), rate on residual impairment of function.

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and other updates that there is evidence of a positive association between exposure to herbicides used in Vietnam and soft tissue sarcomas.

#23. Rhabdomyosarcoma (RMS), DC 5329

Rhabdomyosarcoma (RMS) is a rare type of cancer that forms in soft tissue, specifically in the skeletal muscle tissue or the hollow organs such as the bladder or uterus. 

Rhabdomyosarcoma can occur at any age, but it most often affects children.

Medical research has found evidence of a positive association between Rhabdomyosarcoma and exposure to Agent Orange.

The VA rates Rhabdomyosarcoma under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 5329, Sarcoma, soft tissue (muscle, fat, or fibrous connective tissue).

The VA rating for Rhabdomyosarcoma due to Agent Orange is 100 percent.

What is the VA rating for Rhabdomyosarcoma cancer due to Agent Orange exposure?

  • Rhabdomyosarcoma, soft tissue cancer (muscle, fat, or fibrous connective tissue) rate at 100%.

Note: A rating of 100 percent shall continue beyond the cessation of any surgery, radiation treatment, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local recurrence or metastasis of Rhabdomyosarcoma, rate on residual impairment of function.

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and other updates that there is evidence of a positive association between exposure to herbicides used in Vietnam and soft tissue sarcomas.

#24. Ectomesenchymoma, DC 5329

Ectomesenchymoma is a rare and fast-growing tumor of the nervous system or soft tissue.

Ectomesenchymoma may form in the head and neck, abdomen, perineum, scrotum, or limbs.

Medical research has found evidence of a positive association between Ectomesenchymoma and exposure to Agent Orange.

The VA rates Ectomesenchymoma under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 5329, Sarcoma, soft tissue (muscle, fat, or fibrous connective tissue).

The VA rating for Ectomesenchymoma due to Agent Orange is 100 percent.

What is the VA rating for Ectomesenchymoma cancer due to Agent Orange exposure?

  • Ectomesenchymoma, soft tissue cancer (muscle, fat, or fibrous connective tissue) rate at 100%.

Note: A rating of 100 percent shall continue beyond the cessation of any surgery, radiation treatment, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local recurrence or metastasis of Ectomesenchymoma, rate on residual impairment of function.

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and other updates that there is evidence of a positive association between exposure to herbicides used in Vietnam and soft tissue sarcomas.

#25. Angiosarcoma (hemangiosarcoma and lymphangiosarcoma), DC 5329

Angiosarcoma (hemangiosarcoma and lymphangiosarcoma) is a rare cancer that develops in the inner lining of blood vessels and lymph vessels.

While this form of cancer can occur anywhere in the body, it is most often found in the skin, breast, liver and spleen.

Medical research has found evidence of a positive association between Angiosarcoma (hemangiosarcoma and lymphangiosarcoma) and exposure to Agent Orange.

The VA rates Angiosarcoma (hemangiosarcoma and lymphangiosarcoma) under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 5329, Sarcoma, soft tissue (muscle, fat, or fibrous connective tissue).

The VA rating for Angiosarcoma (hemangiosarcoma and lymphangiosarcoma) due to Agent Orange is 100 percent.

What is the VA rating for Angiosarcoma (hemangiosarcoma and lymphangiosarcoma) cancer due to Agent Orange exposure?

  • Angiosarcoma (hemangiosarcoma and lymphangiosarcoma), soft tissue cancer (muscle, fat, or fibrous connective tissue) rate at 100%.

Note: A rating of 100 percent shall continue beyond the cessation of any surgery, radiation treatment, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local recurrence or metastasis of Angiosarcoma (hemangiosarcoma and lymphangiosarcoma), rate on residual impairment of function.

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and other updates that there is evidence of a positive association between exposure to herbicides used in Vietnam and soft tissue sarcomas.

#26. Proliferating (systemic) angioendotheliomatosis, DC 5329

Angioendotheliomatosis proliferans systemisata is a rare disease entity characterized by a predominantly intravascular proliferation of tumor cells.

The most common type is the malignant form (cancerous), which is an angiotropic intravascular malignant B-cell lymphoma.

Medical research has found evidence of a positive association between Proliferating (systemic) angioendotheliomatosis and exposure to Agent Orange.

The VA rates Proliferating (systemic) angioendotheliomatosis under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 5329, Sarcoma, soft tissue (muscle, fat, or fibrous connective tissue).

The VA rating for Proliferating (systemic) angioendotheliomatosis due to Agent Orange is 100 percent.

What is the VA rating for Proliferating (systemic) angioendotheliomatosis cancer due to Agent Orange exposure?

  • Proliferating (systemic) angioendotheliomatosis, soft tissue cancer (muscle, fat, or fibrous connective tissue) rate at 100%.

Note: A rating of 100 percent shall continue beyond the cessation of any surgery, radiation treatment, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local recurrence or metastasis of Proliferating (systemic) angioendotheliomatosis, rate on residual impairment of function.

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and other updates that there is evidence of a positive association between exposure to herbicides used in Vietnam and soft tissue sarcomas.

#27. Malignant glomus tumor, DC 5329

Malignant glomus tumors are rare mesenchymal neoplastic lesions arising from glomus bodies that are involved in skin thermoregulation.

A Malignant glomus tumor is a type of cancer with a deep location and a size of more than 2 cm, or atypical mitotic figures, or moderate to high nuclear grade and > or =5 mitotic figures/50 HPF.

Medical research has found evidence of a positive association between Malignant glomus tumors and exposure to Agent Orange.

The VA rates Malignant glomus tumor under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 5329, Sarcoma, soft tissue (muscle, fat, or fibrous connective tissue).

The VA rating for Malignant glomus tumor due to Agent Orange is 100 percent.

What is the VA rating for Malignant glomus tumor cancer due to Agent Orange exposure?

  • Malignant glomus tumor, soft tissue cancer (muscle, fat, or fibrous connective tissue) rate at 100%.

Note: A rating of 100 percent shall continue beyond the cessation of any surgery, radiation treatment, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local recurrence or metastasis of Malignant glomus tumor, rate on residual impairment of function.

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and other updates that there is evidence of a positive association between exposure to herbicides used in Vietnam and soft tissue sarcomas.

#28. Malignant hemangiopericytoma, DC 5329

Malignant hemangiopericytomas are very rare tumors that mainly develop in the soft tissues.

In extremely rare instances, they may occur as primary bone tumors.

Medical research has found evidence of a positive association between Malignant hemangiopericytoma and exposure to Agent Orange.

The VA rates Malignant hemangiopericytoma under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 5329, Sarcoma, soft tissue (muscle, fat, or fibrous connective tissue).

The VA rating for Malignant hemangiopericytoma due to Agent Orange is 100 percent.

What is the VA rating for Malignant hemangiopericytoma cancer due to Agent Orange exposure?

  • Malignant hemangiopericytoma, soft tissue cancer (muscle, fat, or fibrous connective tissue) rate at 100%.

Note: A rating of 100 percent shall continue beyond the cessation of any surgery, radiation treatment, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local recurrence or metastasis of Malignant hemangiopericytoma, rate on residual impairment of function.

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and other updates that there is evidence of a positive association between exposure to herbicides used in Vietnam and soft tissue sarcomas.

#29. Synovial sarcoma (malignant synovioma), DC 5329

Synovial sarcoma (malignant synovioma) is a type of cancer that can come from different types of soft tissue, such as muscle or ligaments.

It is typically found in the arm, leg, or foot, and near joints such as the wrist or ankle.

It can also form in soft tissues in the lung or abdomen.

Medical research has found evidence of a positive association between Synovial sarcoma (malignant synovioma) and exposure to Agent Orange.

The VA rates Synovial sarcoma (malignant synovioma) under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 5329, Sarcoma, soft tissue (muscle, fat, or fibrous connective tissue).

The VA rating for Synovial sarcoma (malignant synovioma) due to Agent Orange is 100 percent.

What is the VA rating for Synovial sarcoma (malignant synovioma) cancer due to Agent Orange exposure?

  • Synovial sarcoma (malignant synovioma), soft tissue cancer (muscle, fat, or fibrous connective tissue) rate at 100%.

Note: A rating of 100 percent shall continue beyond the cessation of any surgery, radiation treatment, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local recurrence or metastasis of Synovial sarcoma (malignant synovioma), rate on residual impairment of function.

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and other updates that there is evidence of a positive association between exposure to herbicides used in Vietnam and soft tissue sarcomas.

#30. Malignant giant cell tumor of tendon sheath, DC 5329

Malignant giant cell tumor of tendon sheath is a slow-growing tumor associated with mechanical pain, most commonly in the hands and feet.

It typically appears as a nodular mass near a tendon sheath

Medical research has found evidence of a positive association between Malignant giant cell tumor of tendon sheath and exposure to Agent Orange.

The VA rates Malignant giant cell tumor of tendon sheath under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 5329, Sarcoma, soft tissue (muscle, fat, or fibrous connective tissue).

The VA rating for Malignant giant cell tumor of tendon sheath due to Agent Orange is 100 percent.

What is the VA rating for Malignant giant cell tumor of tendon sheath cancer due to Agent Orange exposure?

  • Malignant giant cell tumor of tendon sheath, soft tissue cancer (muscle, fat, or fibrous connective tissue) rate at 100%.

Note: A rating of 100 percent shall continue beyond the cessation of any surgery, radiation treatment, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local recurrence or metastasis of Malignant giant cell tumor of tendon sheath, rate on residual impairment of function.

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and other updates that there is evidence of a positive association between exposure to herbicides used in Vietnam and soft tissue sarcomas.

#31. Malignant schwannoma, DC 5329

Malignant schwannomas are rare sarcomas that arise from the sheath of Schwann surrounding peripheral nerve fibers.

These tumors may arise spontaneously in adult patients or may occur with reportedly increased frequency in patients with neurofibromatosis Type I.

The tumors have had a reputation for malignancy with rapid metastasis, especially when they arise in relation to neurofibromatosis.

Medical research has found evidence of a positive association between Malignant schwannomas and exposure to Agent Orange.

The VA rates Malignant schwannoma under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 5329, Sarcoma, soft tissue (muscle, fat, or fibrous connective tissue).

The VA rating for Malignant schwannoma due to Agent Orange is 100 percent.

What is the VA rating for Malignant schwannoma cancer due to Agent Orange exposure?

  • Malignant schwannoma, soft tissue cancer (muscle, fat, or fibrous connective tissue) rate at 100%.

Note: A rating of 100 percent shall continue beyond the cessation of any surgery, radiation treatment, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local recurrence or metastasis of Malignant schwannoma, rate on residual impairment of function.

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and other updates that there is evidence of a positive association between exposure to herbicides used in Vietnam and soft tissue sarcomas.

#32. Malignant mesenchymoma, DC 5329

Malignant mesenchymomas are rare and aggressive soft tissue or bone cancers that contain two or more subtypes of sarcoma.

Medical research has found evidence of a positive association between Malignant mesenchymoma and exposure to Agent Orange.

The VA rates Malignant mesenchymoma under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 5329, Sarcoma, soft tissue (muscle, fat, or fibrous connective tissue).

The VA rating for Malignant mesenchymoma due to Agent Orange is 100 percent.

What is the VA rating for Malignant mesenchymoma cancer due to Agent Orange exposure?

  • Malignant mesenchymoma, soft tissue cancer (muscle, fat, or fibrous connective tissue) rate at 100%.

Note: A rating of 100 percent shall continue beyond the cessation of any surgery, radiation treatment, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local recurrence or metastasis of Malignant mesenchymoma, rate on residual impairment of function.

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and other updates that there is evidence of a positive association between exposure to herbicides used in Vietnam and soft tissue sarcomas.

#33. Malignant granular cell tumor, DC 5329

A Malignant granular cell tumor is a rare type of soft tissue cancerous tumor that usually begins in Schwann cells (cells that hold nerve cells in place).

While it can occur anywhere in the body, it usually occurs in or under the skin of the head and neck, especially the mouth or tongue.

Malignant granular cell tumors may also occur in the chest, breast, esophagus, stomach, or other internal organ.

Medical research has found evidence of a positive association between Malignant granular cell tumor and exposure to Agent Orange.

The VA rates Malignant granular cell tumor under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 5329, Sarcoma, soft tissue (muscle, fat, or fibrous connective tissue).

The VA rating for Malignant granular cell tumor due to Agent Orange is 100 percent.

What is the VA rating for Malignant granular cell tumor cancer due to Agent Orange exposure?

  • Malignant granular cell tumor, soft tissue cancer (muscle, fat, or fibrous connective tissue) rate at 100%.

Note: A rating of 100 percent shall continue beyond the cessation of any surgery, radiation treatment, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local recurrence or metastasis of Malignant granular cell tumor, rate on residual impairment of function.

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and other updates that there is evidence of a positive association between exposure to herbicides used in Vietnam and soft tissue sarcomas.

#34. Alveolar soft part sarcoma (ASPS), DC 5329

Alveolar soft part sarcoma (ASPS) is a soft tissue cancer that begins in muscle, fat, or nerves.

It may also be called alveolar soft tissue sarcoma, alveolar sarcoma of soft parts, or ASP sarcoma.

Medical research has found evidence of a positive association between Alveolar soft part sarcoma and exposure to Agent Orange.

The VA rates Alveolar soft part sarcoma under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 5329, Sarcoma, soft tissue (muscle, fat, or fibrous connective tissue).

The VA rating for Alveolar soft part sarcoma due to Agent Orange is 100 percent.

What is the VA rating for Alveolar soft part sarcoma cancer due to Agent Orange exposure?

  • Alveolar soft part sarcoma, soft tissue cancer (muscle, fat, or fibrous connective tissue) rate at 100%.

Note: A rating of 100 percent shall continue beyond the cessation of any surgery, radiation treatment, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local recurrence or metastasis of Alveolar soft part sarcoma, rate on residual impairment of function.

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and other updates that there is evidence of a positive association between exposure to herbicides used in Vietnam and soft tissue sarcomas.

#35. Epitheliod sarcoma, DC 5329

Epithelioid sarcoma is a rare and slow-growing form of soft tissue cancer.

It normally begins in the soft tissue under the skin of a finger, hand, forearm, lower leg or foot, though it can start in other areas of the body.

Generally, epithelioid sarcoma starts as a small firm growth or lump that’s painless.

Medical research has found evidence of a positive association between Epitheliod sarcoma and exposure to Agent Orange.

The VA rates Epitheliod sarcoma under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 5329, Sarcoma, soft tissue (muscle, fat, or fibrous connective tissue).

The VA rating for Epitheliod sarcoma due to Agent Orange is 100 percent.

What is the VA rating for Epitheliod sarcoma cancer due to Agent Orange exposure?

  • Epitheliod sarcoma, soft tissue cancer (muscle, fat, or fibrous connective tissue) rate at 100%.

Note: A rating of 100 percent shall continue beyond the cessation of any surgery, radiation treatment, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local recurrence or metastasis of Epitheliod sarcoma, rate on residual impairment of function.

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and other updates that there is evidence of a positive association between exposure to herbicides used in Vietnam and soft tissue sarcomas.

#36. Clear cell sarcoma of tendons and aponeuroses, DC 5329

Clear cell sarcoma of soft tissue is a rare type of cancer primarily affecting young adults between 20 to 40 years old.

Clear cell sarcoma tumors tend to grow attached to tendons in the limbs, especially in the feet and hands.

They also sometimes develop in the gastrointestinal tract, attached with the bottom layers of the skin, and in locations throughout the torso.

Medical research has found evidence of a positive association between Clear cell sarcoma of tendons and aponeuroses and exposure to Agent Orange.

The VA rates Clear cell sarcoma of tendons and aponeuroses under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 5329, Sarcoma, soft tissue (muscle, fat, or fibrous connective tissue).

The VA rating for Clear cell sarcoma of tendons and aponeuroses due to Agent Orange is 100 percent.

What is the VA rating for Clear cell sarcoma of tendons and aponeuroses cancer due to Agent Orange exposure?

  • Clear cell sarcoma of tendons and aponeuroses, soft tissue cancer (muscle, fat, or fibrous connective tissue) rate at 100%.

Note: A rating of 100 percent shall continue beyond the cessation of any surgery, radiation treatment, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local recurrence or metastasis of Clear cell sarcoma of tendons and aponeuroses, rate on residual impairment of function.

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and other updates that there is evidence of a positive association between exposure to herbicides used in Vietnam and soft tissue sarcomas.

#37. Extra-skeletal Ewing’s sarcoma, DC 5329

Extra-skeletal Ewing’s sarcoma is a rare type of Ewing sarcoma that forms in soft tissue instead of bone.

It usually occurs in the chest, pelvis, thigh, foot, or spine.

Medical research has found evidence of a positive association between Extra-skeletal Ewing’s sarcoma and exposure to Agent Orange.

The VA rates Extra-skeletal Ewing’s sarcoma under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 5329, Sarcoma, soft tissue (muscle, fat, or fibrous connective tissue).

The VA rating for Extra-skeletal Ewing’s sarcoma due to Agent Orange is 100 percent.

What is the VA rating for Extra-skeletal Ewing’s sarcoma cancer due to Agent Orange exposure?

  • Extra-skeletal Ewing’s sarcoma, soft tissue cancer (muscle, fat, or fibrous connective tissue) rate at 100%.

Note: A rating of 100 percent shall continue beyond the cessation of any surgery, radiation treatment, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local recurrence or metastasis of Extra-skeletal Ewing’s sarcoma, rate on residual impairment of function.

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and other updates that there is evidence of a positive association between exposure to herbicides used in Vietnam and soft tissue sarcomas.

#38. Congenital and infantile fibrosarcoma (CIF), DC 5329

Congenital infantile fibrosarcoma (CIF) is a soft-tissue tumor occurring during the first 2 years of life, most commonly in the extremities.

CIF is frequently initially misdiagnosed as a vascular tumor, but its association with bleeding and coagulopathy has not been well characterized.

Medical research has found evidence of a positive association between Congenital and infantile fibrosarcoma and exposure to Agent Orange.

The VA rates Congenital and infantile fibrosarcoma under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 5329, Sarcoma, soft tissue (muscle, fat, or fibrous connective tissue).

The VA rating for Congenital and infantile fibrosarcoma due to Agent Orange is 100 percent.

What is the VA rating for Congenital and infantile fibrosarcoma cancer due to Agent Orange exposure?

  • Congenital and infantile fibrosarcoma, soft tissue cancer (muscle, fat, or fibrous connective tissue) rate at 100%.

Note: A rating of 100 percent shall continue beyond the cessation of any surgery, radiation treatment, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local recurrence or metastasis of Congenital and infantile fibrosarcoma, rate on residual impairment of function.

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and other updates that there is evidence of a positive association between exposure to herbicides used in Vietnam and soft tissue sarcomas.

#39. Malignant ganglioneuroma, DC 5329

Malignant ganglioneuromas (GN) and ganglioneuroblastomas (GNB) are soft-tissue tumors of the sympathetic nervous system that originate from neural crest sympathogonia.

Ganglioneuromas often present as a solitary, painless, slow-growing mass consisting of ganglion cells, Schwann cells, and fibrous tissue.

Medical research has found evidence of a positive association between Malignant ganglioneuroma and exposure to Agent Orange.

The VA rates Malignant ganglioneuroma under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 5329, Sarcoma, soft tissue (muscle, fat, or fibrous connective tissue).

The VA rating for Malignant ganglioneuroma due to Agent Orange is 100 percent.

What is the VA rating for Malignant ganglioneuroma cancer due to Agent Orange exposure?

  • Malignant ganglioneuroma, soft tissue cancer (muscle, fat, or fibrous connective tissue) rate at 100%.

Note: A rating of 100 percent shall continue beyond the cessation of any surgery, radiation treatment, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local recurrence or metastasis of Malignant ganglioneuroma, rate on residual impairment of function.

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its 1994 report “Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam” and other updates that there is evidence of a positive association between exposure to herbicides used in Vietnam and soft tissue sarcomas.

#40. Bladder cancer, DC 7528

Bladder cancer is a common type of cancer that begins in the cells of the bladder.

The bladder is a hollow muscular organ in your lower abdomen that stores urine.

Bladder cancer most often begins in the cells (urothelial cells) that line the inside of your bladder.

Medical research has found evidence of a positive association between Bladder cancer and exposure to Agent Orange.

The VA rates Bladder cancer under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 7528, Malignant neoplasms of the genitourinary system

The VA rating for Bladder cancer due to Agent Orange is 100 percent.

What is the VA rating for Bladder cancer due to Agent Orange exposure?

  • Bladder cancer (malignant neoplasms of the genitourinary system) rate at 100%.

Note: Following the cessation of surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure, the rating of 100 percent shall continue with a mandatory VA examination at the expiration of six months. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e). If there has been no local reoccurrence or metastasis, rate on residuals of Bladder cancer as voiding dysfunction or renal dysfunction, whichever is predominant.

Medical Research: A 2014 National Academy of Sciences study reported that epidemiologic data was suggestive of an association between bladder cancer and Agent Orange exposure, based on evidence that higher levels of exposure are associated with an approximately two-fold increase in death from bladder cancer.

#41. Hypothyroidism, DC 7903

Hypothyroidism, or “underactive thyroid,” is a condition in which the thyroid gland doesn’t produce enough of certain crucial hormones.

Hypothyroidism has been directly linked to Agent Orange exposure.

The VA rates Hypothyroidism under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 7903, Hypothyroidism.

VA disability ratings for Hypothyroidism are either 30% or 100%.

The highest scheduler VA rating for Hypothyroidism is 100 percent.

What are the VA ratings for Hypothyroidism due to Agent Orange exposure?

  • Hypothyroidism manifesting as myxedema (cold intolerance, muscular weakness, cardiovascular involvement (including, but not limited to hypotension, bradycardia, and pericardial effusion), and mental disturbance (including, but not limited to dementia, slowing of thought and depression) rate at 100%.
  • Hypothyroidism without myxedema rate at 30%.

Pro Tip: This evaluation shall continue for six months beyond the date that an examining physician has determined crisis stabilization. Thereafter, the residual effects of hypothyroidism shall be rated under the appropriate diagnostic code(s) within the appropriate body system(s) (e.g., eye, digestive, and mental disorders).

Medical Research: A 2016 study found suggestive evidence of an association between Hypothyroidism and Agent Orange. For Hypothyroidism, research results from a large study of Korean veterans who served in the Vietnam War were suggestive of a connection to Agent Orange exposure. 

#42. Parkinsonism, DC 8004

Parkinsonism is any condition that causes a combination of the movement abnormalities seen in Parkinson’s disease, such as tremor and imbalance, slow movement, impaired speech, or muscle stiffness.

Parkinsonism has been directly linked to Agent Orange exposure.

The VA rates Parkinsonism under CFR 38, Part 4, VA Schedule of Ratings, Diagnostic Code 8004, Paralysis agitans.

The only scheduler disability rating available for Parkinsonism is 30 percent.

What is the VA rating for Parkinsonism due to Agent Orange exposure?

  • Parkinsonism (Paralysis agitans) rate at 30%.

Medical Research: The Health and Medicine Division (formally known as the Institute of Medicine) of the National Academy of Sciences, Engineering, and Medicine concluded in its report “Veterans and Agent Orange: Update 2008” released July 24, 2009, that there is “suggestive but limited evidence that exposure to Agent Orange and other herbicides used during the Vietnam War is associated with an increased chance of developing Parkinson’s disease.”

What Conditions Do NOT Qualify for the Agent Orange Presumptive List?

Conditions Not on the Agent Orange Presumptive List

Under the Agent Orange Act of 1991, the VA receives from NAS periodic reviews and summaries of the scientific evidence concerning the association between exposure to herbicides and diseases suspected to be associated with those exposures. 

Based on cumulative scientific data reported by NAS since 1993, the VA has determined that a positive association does not exist between herbicide exposure and the following conditions and that a presumption of service connection is not warranted for any of the conditions:

Various Forms of Cancer:

  • Bone and joint
  • Brain and nervous system (including eye)
  • Breast
  • Digestive (including esophagus, stomach, colon-rectum, small intestine, and anus)
  • Endocrine (including thyroid and thymus)
  • Hepatobiliary (liver, gallbladder, and bile ducts) and pancreatic
  • Leukemia (except chronic B-cell leukemias such as CLL and hairy cell)
  • Nasal cavity (including ears and sinuses)
  • Oral cavity (including lips and tongue)
  • Pharynx (including tonsils)
  • Pleura, mediastinum, and other unspecified sites within the respiratory system and intrathoracic organs
  • Renal (kidney and renal pelvis)
  • Skin (including melanoma, basal cell carcinoma, and squamous cell carcinoma)
  • Reproductive (including the cervix, uterus, ovary, testes, and penis, but excluding prostate), and
  • Any cancers for which the VA Secretary has not already established a presumption

Other Conditions:

  • Bone conditions
  • Circulatory disorders (except IHD)
  • Cognitive and neuropsychiatric effects
  • Endometriosis
  • Eye problems
  • Gastrointestinal, metabolic, and digestive disorders (including changes in liver enzymes, lipid abnormalities, and ulcers)
  • Hearing loss
  • Immune system disorders (immune suppression, allergy, and autoimmunity)
  • Neurobehavioral (cognitive and neuropsychiatric) disorders
  • Neurodegenerative diseases (including amyotrophic lateral sclerosis (ALS), but excluding Parkinson’s disease and Parkinsonism)
  • Conditions affecting offspring of exposed persons (including neonatal death, infant death, stillborn, low birth weight, birth defects other than spina bifida, and childhood cancer such as acute myeloid leukemia)
  • Chronic peripheral nervous system disorders such as late-onset peripheral neuropathy (but excluding early-onset peripheral neuropathy)
  • Reproductive effects, such as abnormal sperm parameters and infertility, and
  • Respiratory disorders (excluding covered respiratory cancers) such as asthma and chronic obstructive pulmonary disease (COPD)

What is the Average Compensation for Agent Orange?

what is the average compensation for agent orange

VA Ratings for Agent Orange range from 10% to 100% depending on the disability and the Frequency, Severity, and Duration of symptoms (i.e., “severity of symptoms”).

The average compensation for Agent Orange is a 100 percent service connected VA disability rating, which is worth a minimum of $3,332.06 per month in 2022.

Can I Get Agent Orange Compensation Back Pay?

agent orange compensation back pay
agent orange compensation back pay

Yes, you can get back pay for Agent Orange, although the amount of back pay depends on many factors.

When awarding service connection for a disability under 38 CFR 3.309(e), different provisions allow for assignment of an effective date.

In such cases, consider each effective date rule and assign the most advantageous effective date that applies for the facts of the case.

VA Raters use the table below to determine which effective date rule may apply to an award of service connection for an Agent Orange presumptive disability.

Agent Orange Back Pay Effective Date Calculator

Claim StatusEffective DateReference
The veteran filed the claim prior to the date VA added the presumptive disability to 38 CFR 3.309(e)38 CFR 3.816M21-1, Part VIII, Subpart i, 2.B
The veteran met all eligibility criteria for a benefit on the effective date of a liberalizing law change as detailed in M21-1, Part V, Subpart ii, 4.A.6.f38 CFR 3.114(a)M21-1, Part V, Subpart ii, 4.A.6
The veteran is entitled to retroactive payment of benefits based on PL 116-2338 U.S.C. 1116ABlue Water Navy Standard Operating Procedure
The claim was previously denied because available service records did not establish the veteran had qualifying service, and Newly received service records establish service in a qualifying location38 CFR 3.156(c)M21-1, Part VIII, Subpart i, 1.B.4.b-d
None of the above special provisions apply38 CFR 3.400, or 38 CFR 3.2500.M21-1, Part V, Subpart ii, 4.A

What is the VA Decision on Hypertension and Agent Orange?

What is the VA Decision on Hypertension and Agent Orange

Even though various research studies have shown a positive correlation between Hypertension and Agent Orange Exposure, Hypertension is still not on the Agent Orange Presumptive List as of March 2022.

However, VA Claims Insider expects that Hypertension will be added for presumptive service connection due to Agent Orange Exposure in the very near future.

A 2016 study found that, “Occupational herbicide exposure history and Vietnam-service-status were significantly associated with Hypertension risk.”

A 2018 study concluded that, “Sufficient evidence of an association between exposure to at least one of the chemicals of interest [Agent Orange] and Hypertension.

Finally, March 2021 testimony by Dr. Karl Kelsey before the Senate VA Committee added that, “There is statistically significant support for an association between herbicide exposure and self-reported, physician-diagnosed hypertension.”

About the Author

Brian Reese
Brian Reese

Brian Reese

Founder & CEO

Brian Reese is VA benefits expert, author of the #1 Amazon Bestseller You Deserve It: The Definitive Guide to Getting the Veteran Benefits You’ve Earned, and founder of VA Claims Insider – “The Most Trusted Name in Education-Based Resources for Veterans.”

His frustration with the 8-step VA disability claims process led him to create “VA Claims Insider,” which provides U.S. military veterans with tips, strategies, and lessons learned for successfully submitting or re-submitting a winning VA disability compensation claim.

Brian is also the CEO of Military Disability Made Easy, which is the world’s largest free searchable database for all things related to DoD disability and VA disability claims and has served more than 4,600,000 military members and veterans since its founding in 2013.

His eBook, the “9 Secrets Strategies for Winning Your VA Disability Claim” has been downloaded more than 300,000 times in the past three years and is the #1 rated free VA disability claims guide for veterans.

He is a former active duty Air Force officer with extensive experience leading hundreds of individuals and multi-functional teams in challenging international environments, including a combat tour to Afghanistan in 2011 supporting Operation ENDURING FREEDOM.

Brian is a Distinguished Graduate of Management from the United States Air Force Academy, Colorado Springs, CO and he holds an MBA from Oklahoma State University’s Spears School of Business, Stillwater, OK, where he was a National Honor Scholar (Top 1% of Graduate School class).

Related Articles

Featured Resources

Elite Membership

Dear Veteran,
Here’s the brutal truth about VA disability claims:

According to our data, 8/10 (80%) of veterans reading this message right now are underrated by the VA…

This means you do NOT currently have the VA disability rating and compensation YOU deserve, and you could be missing out on thousands of dollars of tax-free compensation and benefits each month.

As a fellow disabled Veteran this is shameful and I’m on a mission to change it.

Brian Reese here, Air Force service-disabled Veteran and Founder @ VA Claims Insider.

Since 2016, VA Claims Insider has helped thousands of Veterans just like you get the VA rating and compensation they deserve in less time.

If accepted into our ELITE membership program, you’ll get free up-front access and permission to use $13,119 worth of proprietary VA claim resources, including access to our network of independent medical professionals for medical examinations, disability evaluations, and credible Medical Nexus Letters, which could help you get a HIGHER VA rating in LESS time.

It’s FREE to get started, so click “Go Elite Now” below to complete our 3-step intake process.

  1. Complete Basic Information
  2. Sign Members Agreement
  3. Join the Mastermind Group

If you’re stuck, frustrated, underrated, and currently rated between 0%-90%, VA Claims Insider Elite is for you!

Click “Go Elite Now” below to get started today and a member of our team will be in touch within minutes.

Go Elite Now!

Why Choose VA Claims Insider

You’ve exhausted your free resources

You're not alone. Thousands of other Veterans in our Community are here for you.

Veteran Community

You’re ready to get the rating you deserve

We know the pain of feeling stuck, frustrated, and alone, and we want to make this process as easy and painless as possible for you.

Explore Elite Membership

We win ONLY when YOU win

Hear from fellow Veterans just like you, with many of our Veteran Success Managers having gone through our programs.

Schedule a Call